It is currently Fri Jan 30, 2015 9:43 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

New technology might allow for better imaging of CCSVI

Brains, veins and bones as you've never seen them: Scanner reveals gruesome, high-definition images of the human body

Next-generation GE scanners are being used by doctors in Florida
They hope to make medical scanning cheaper, easier and more accurate
Dubbed 'Revolution CT', the scanners beam x-rays through a patient's body from which a computer reconstructs a detailed image, slice by slice
Technology can build an image of a complete heart in a single heartbeat

By ...


India Stem Cell Scam in Newspaper today about "Dr." Broeska

This is by the Winnipeg Free Press in regards to "Dr." Doug Broeska's CTP in India.

http://www.winnipegfreepress.com/breaki ... -top-story
Read more : India Stem Cell Scam in Newspaper today about "Dr." Broeska | Views : 413 | Replies : 4 | Forum : General Discussion


Possible novel therapy for Multiple Sclerosis discovered

Semaphorin 4D (SEMA4D) is a viable target for therapy in neuroinflammatory and neurodegenerative diseases like multiple sclerosis (MS), according to findings published in Neurobiology of Disease.

Researchers from Vaccinex, Inc. in Rochester, New York conducted a study of mouse models of experimental autoimmune encephalomyelitis (EAE) – a surrogate for human MS – in order to determine if SEMA4D or any specific novel molecular therapy would make a viable target. The investigators created a monoclonal antibody ...
Read more : Possible novel therapy for Multiple Sclerosis discovered | Views : 400 | Replies : 0 | Forum : General Discussion


Update on progress of progressive MS drug MD1003

MedDay provides update on progress of progressive MS drug MD1003

MedDay has provided an update on the progress of its lead product MD1003 for the treatment of primary and secondary progressive multiple sclerosis (MS), which is expected to complete its first pivotal study in Q1 2015. A second pivotal study is on track for completion by the end of 2015.... Read More - http://www.ms-uk.org/emergingtherapies
Read more : Update on progress of progressive MS drug MD1003 | Views : 398 | Replies : 3 | Forum : Drug Pipeline


Migraines & Clusters Headaches

Hello all
New to the group. I am researching. My neuro wants to test me for MS. I have been having unexplained migraines for going on 6 years, and they severely Impact my wk and daily life.

I have looked over the other symptoms, which I believe I can fall into, but can be vague.
B-12
V-D
I have an optical Nevis
Bladder issue...
Fatigue (who isn't)
Extremely LOW BP which I always accounted for ...
Read more : Migraines & Clusters Headaches | Views : 260 | Replies : 7 | Forum : Undiagnosed


Study Hints Gut Microbiome Plays A Role in MS

Study Hints Gut Microbiome Plays A Role in Multiple Sclerosis

Boston—The gastrointestinal tract may seem like an odd place to look for insight
into a neurologic disease, but a small study has identified an association between
two types of bacteria found in the gut and the development of multiple sclerosis.

Link
Read more : Study Hints Gut Microbiome Plays A Role in MS | Views : 280 | Replies : 0 | Forum : General Discussion


SMC approves the use of peginterferon beta 1a (Plegridy)

Scottish Medicines Consortium approves the use of peginterferon beta 1a (Plegridy)

The SMC has accepted peginterferon-beta-1a for use in adult patients for the treatment of relapsing remitting multiple sclerosis because the balance of costs and benefits mean that it offers value for money....... Read More - http://www.ms-uk.org/plegridy
Read more : SMC approves the use of peginterferon beta 1a (Plegridy) | Views : 227 | Replies : 0 | Forum : General Discussion


Study reveals new emotional challenges faced by MS patients

Multiple Sclerosis (MS) patients are less able to regulate their emotions and have a poorer quality of life than people who don't have the disease, according to research carried out at the University of Aberdeen.

MS currently affects around 100,000 people in the UK and Scotland has one of the highest incidences of the disease in the world. While usually considered to be primarily a disease that affects movement, there are high instances of emotion ...
Read more : Study reveals new emotional challenges faced by MS patients | Views : 267 | Replies : 0 | Forum : General Discussion


ISET conference 2015

Hardly anything of interest despite 5 days of sessions.
Wednesday 5:50 p.m. Central Venous Stenosis: Techniques and Results Dr. Trerotola
Wednesday 5:20 p.m. Stent Selection for Venous Recanalization Dr. Zwiebel
http://iset.org/program-2#day-v-wednesday
11:00 a.m. Venous Thoracic Outlet Syndrome: Diagnosis and Treatment Algorithms Dr. Comerota
11:40 a.m. Vascular Compressive Disorders: More Than Thoracic Outlet Syndromes and May-Thurner Syndrome Dr. Matsumoto
11:48 a.m. Central Venous Recanalization After Failure of Conventional Techniques Dr. Guimaraes
Tuesday ...
Read more : ISET conference 2015 | Views : 248 | Replies : 0 | Forum : Chronic Cerebrospinal Venous Insufficiency (CCSVI)




 

Login  •  Register


Statistics

Total posts 223346 • Total topics 23221 • Total members 14698


Contact us | Terms of Service